Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Glitazones and Endothelial Function (GATE)
This study has been terminated.
( Terminated at 50% enrollment due to recent concerns about rosiglitazone )
Study NCT00203632 Information provided by University of Calgary
First Received on September 13, 2005. Last Updated on October 30, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
rosiglitazone/placebo
Additional drug interventions recognized in this trial
Rosiglitazone
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Calgary
GlaxoSmithKline
Back to top of Main Content